Technology
Health
Pharmaceutical

Verrica Pharmaceuticals

$12.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.71 (-5.56%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell VRCA and other stocks, options, ETFs, and crypto commission-free!

About

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. Read More The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Employees
ā€”
Headquarters
West Chester, Pennsylvania
Founded
2013
Market Cap
310.16M
Price-Earnings Ratio
ā€”
Dividend Yield
ā€”
Average Volume
65.82K
High Today
$12.74
Low Today
$11.90
Open Price
$12.74
Volume
11.61K
52 Week High
$23.29
52 Week Low
$6.44

Collections

Technology
Health
Pharmaceutical
Medical
Therapy
2018 IPO
US
North America

News

Markets InsiderMar 2

Verrica Pharmaceuticals Presents Positive Results from Two Phase 3 Clinical Trials of VP-102 in Late-Breaking Oral Presentation at the 2019 American Academy of Dermatology Meeting

ā€“ CAMP-1 and CAMP-2 trials of VP-102 for the treatment of molluscum contagiosum successfully met their primary endpoints ā€“ ā€“ Molluscum contagiosum is a highly contagious, significantly undertreated viral skin disease that affects approximately six million people in the U.S., many of them children, with no-FDA approved treatment ā€“ WEST CHESTER, Pa., March 02, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a medical dermatology company committed to the development and commer...

230

Earnings

-$0.30
-$0.28
-$0.27
-$0.25
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.27 per share
Actual
-$0.30 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.